Purnima Sah; Navyaberi · DistrictNews · 2026-09-09
Mounjaro becomes India’s top-selling GLP-1 drug as diabetes, weight-loss
Mounjaro maker Eli Lilly leads a fast-growing market that reached Rs 2,333 crore, with injectable GLP-1 medicines now accounting for 86% of sales. Mounjaro becomes India’s top-selling GLP-1 drug as diabetes, weight-loss medicines surge.
Read original on Purnima Sah; Navyaberi Get the app
Licensed summary · LicensedSummary
Related briefs
- Dial 112 to Report Forced Money Demands by Hijras, Says DGP C.V. Anand
- Open a Savings Account in Minutes with Full Video Banking and Zero Paperwork; AU
- Delhi PG Collapse: One Of Operators Arrested Days After Seven Killed
- Adani Enterprises Executes Shareholder Agreement to Raise Funds in Adani
- Largecap safety trade ? 8 Nifty stocks test investor patience with losses for